Gaithersburg company lands $10.2M DOD contract for war on superbugs
The federal government has tapped a local company to help defend against superbugs.
Gaithersburg’s Adaptive Phage Therapeutics Inc. has earned a $10.2 million contract with the Department of Defense to help advance PhageBank, APT's collection of viruses that target specific pathogens and kill drug-resistant bacteria. The ultimate goal is to make its therapy for drug-resistant i nfections available to the U.S. military and the public, APT said Wednesday.
A cure for superbugs represents a major…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Sara Gilgore Source Type: news
More News: Biotechnology | Contracts | Government | Health Management | Infectious Diseases | Superbugs